Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common
-
Number of holders
-
263
-
Total 13F shares, excl. options
-
167M
-
Shares change
-
-2.66M
-
Total reported value, excl. options
-
$2.4B
-
Value change
-
-$60.9M
-
Put/Call ratio
-
2.06
-
Number of buys
-
110
-
Number of sells
-
-130
-
Price
-
$14.33
Significant Holders of Bausch Health - Common (VRX) as of Q3 2017
396 filings reported holding VRX - Bausch Health - Common as of Q3 2017.
Bausch Health - Common (VRX) has 263 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 167M shares
.
Largest 10 shareholders include PAULSON & CO. INC. (20.8M shares), ValueAct Holdings, L.P. (18M shares), VANGUARD GROUP INC (7.63M shares), Connor, Clark & Lunn Investment Management Ltd. (6.95M shares), MILLER VALUE PARTNERS, LLC (6.88M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (5.71M shares), RENAISSANCE TECHNOLOGIES LLC (4.78M shares), OppenheimerFunds, Inc. (4.48M shares), DIMENSIONAL FUND ADVISORS LP (4.47M shares), and TORONTO DOMINION BANK (4.14M shares).
This table shows the top 263 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.